1. 045 Effect of siponimod on cortical grey matter and thalamic volume in secondary progressive multiple sclerosis. Issue 6 (27th May 2022) Authors: Arnold, Douglas L; Fox, Robert J; Bar-Or, Amit; Cree, Bruce AC; Giovannoni, Gavin; Gold, Ralf; Vermersch, Pat- rick; Meier, Daniela Piani; Arnould, Sophie; Kappos, Ludwig Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 056 Efficacy and safety of the Bruton's tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis over 48 weeks: a randomized, placebo-controlled, phase 2 study. (29th July 2019) Authors: Montalban, Xavier; Arnold, Douglas L; Weber, Martin S; Staikov, Ivan; Piasecka-Stryczynska, Karolina; Gillett, Alan; Martin, Emily C; Syed, Sana; Dangond, Fernando; Wolinsky, Jerry S Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90(2019)e7 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE). Issue 6 (24th May 2018) Authors: Kappos, Ludwig; Wolinsky, Jerry S; Giovannoni, Gavin; Arnold, Douglas L; Lublin, Fred; Wang, Qing; Model, Fabian; Wei, Wei; Garren, Hideki; Manfrini, Marianna; Belachew, Shibeshih; Hauser, Stephen Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 069 Peginterferon beta-1a improves clinical and radiological disease outcomes in patients who are newly diagnosed with relapsing-remitting multiple sclerosis (RRMS): subgroup analysis of advance. Issue 6 (24th May 2018) Authors: Newsome, Scott D; Arnold, Douglas L; Yun, Jang; Meergans, Matthias; Naylor, Maria L Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study. Issue 6 (24th May 2018) Authors: Butzkueven, Helmut; Jeffery, Douglas; Arnold, Douglas L; Filippi, Massimo; Geurts, Jeroen JG; Dong, Qunming; Campbell, Nolan; Licata, Stephanie; Ho, Pei-Ran Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 200 AFFINITY: opicinumab in a targeted population of MS patients. Issue 12 (14th November 2019) Authors: Zhu, Bing; Calabresi, Peter A; Giovanonni, Gavin; Kapoor, Raj; Naismith, Robert; Hartung, Hans-Peter; Arnold, Douglas L; Wolstencroft, Paul; Johnson, Kristina Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: e50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis. Issue 4 (November 2017) Authors: Eisen, Andrew; Greenberg, Benjamin M; Bowen, James D; Arnold, Douglas L; Caggiano, Anthony O Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 3:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. (April 2017) Authors: Khoury, Samia J; Rochon, James; Ding, Linna; Byron, Margie; Ryker, Kristin; Tosta, Patti; Gao, Wendy; Freedman, Mark S; Arnold, Douglas L; Sayre, Peter H; Smilek, Dawn E Journal: Multiple sclerosis Issue: Volume 23:Number 5(2017) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance. (May 2016) Authors: Akbar, Nadine; Till, Christine; Sled, John G; Binns, Malcolm A; Doesburg, Sam M; Aubert-Broche, Berengere; Collins, Donald Louis; Araujo, David; Narayanan, Sridar; Arnold, Douglas L; Lysenko, Magdalena; Banwell, Brenda Journal: Multiple sclerosis Issue: Volume 22:Number 6(2016) Page Start: 792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis. (March 2017) Authors: Lee, Hyunwoo; Narayanan, Sridar; Brown, Robert A; Chen, Jacqueline T; Atkins, Harold L; Freedman, Mark S; Arnold, Douglas L Journal: Multiple sclerosis Issue: Volume 23:Number 3(2017) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗